eGFR from Cystatin C (CKD-EPI 2012)

ورودی‌های بالینی بیمار

حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years

حداقل ۰.۳ — حداکثر ۱۰ • واحد: mg/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
egfr cys
—mL/min/1.73m²
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Reported0–200
Direct Clinical Answer

The eGFR from Cystatin C (CKD-EPI 2012) calculates estimating glomerular filtration rate (eGFR), staging renal disease, and adjusting drug clearances. Key inputs include age. Scores guide adjusting renal medication clearance, coordinating nephrology follow-up, or planning renal replacement therapy. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

eGFR from cystatin C via the CKD-EPI 2012 cystatin C equation: 133 × min(Scys/0.8,1)^−0.499 × max(Scys/0.8,1)^−1.328 × 0.996^age × 0.932 (if female). Useful when creatinine is unreliable (extremes of muscle mass, vegetarian diet). Scys in mg/L; result in mL/min/1.73m².

Clinical Indication

The eGFR from Cystatin C (CKD-EPI 2012) is indicated for bedside clinical practice to support eGFR from cystatin C via the CKD-EPI 2012 cystatin C equation: 133 × min(Scys/0.8,1)^−0.499 × max(Scys/0.8,1)^−1.328 × 0.996^age × 0.932 (if female). Useful when creatinine is unreliable (extremes of muscle mass, vegetarian diet). Scys in mg/L; result in mL/min/1.73m².. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute kidney injury (AKI), chronic kidney disease stages 1-5, or acid-base and fluid-electrolyte disturbances. Clinical application is indicated across Nephrology clinics, hemodialysis units, acute inpatient renal services, and metabolic wards.

Limitations & Contraindications

eGFR estimation equations assume steady-state serum creatinine and become unreliable during unstable AKI, amputations, or extremes of muscle mass.

Clinical Pearls & Action Plan

Serum creatinine lags behind acute reductions in glomerular filtration; monitor hourly urine output and consider cystatin C in evolving AKI.

Formula & Variables:

eGFR = 133 * min(Scys/0.8,1)^-0.499 * max(Scys/0.8,1)^-1.328 * 0.996^age * 0.932 [if female]

Input Parameters

NameTypeRequiredDescription
ageintegerYesAge(years)
sexstringYesSex
scysfloatYesSerum cystatin C(mg/L)

Score Interpretation & Guidance

RangeStageDescription
0–200ReportedeGFR (cystatin C)

Evidence-Based References (EBM)

  • Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29.

Related calculators